Results 121 to 130 of about 15,495 (255)

Evaluating the Educational Value of Artificial Intelligence in Pharmacotherapy Education

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Final‐year medical students frequently make prescribing errors, partly because they have had insufficient training in therapeutic reasoning. Students need to understand the underlying rationale behind a drug choice in order to subsequently apply that knowledge critically and independently.
Mariëlle G. Hartjes   +4 more
wiley   +1 more source

Emergence of Enterobacteriaceae producing extended-spectrum blactamases (ESBLs) in the community

open access: yes, 2005
Enterobacteriaceae, especiallyKlebsiella spp. producing extended-spectrum b-lactamases (ESBLs) such as SHV and TEM types, have been established since the 1980s as a major cause of hospital-acquired infections. Appropriate infection control practices have
Laurent Poirel   +4 more
core   +1 more source

Doxycycline for ESBL-E Cystitis

open access: yesClinical Infectious Diseases, 2020
Tomasz Jodlowski   +2 more
openaire   +2 more sources

Biovigilance in Faecal Microbiota Transplantation: 7‐Year Cohort Study and Framework for Microbiological Assessments of Infectious Adverse Events

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 5, June 2026.
ABSTRACT Background and Aims Faecal microbiota transplantation (FMT) is increasingly used. However, no systematic approach exists to assess infectious risks after FMT, leading to underreporting. We evaluated infectious complications at the Netherlands Donor Feces Bank (NDFB) and proposed a structured biovigilance approach aligned with the EU Regulation
V. O. Chernova   +10 more
wiley   +1 more source

Molecular epidemiology of ESBLs genes and multi-drug resistance in diarrheagenic Escherichia Coli strains isolated from adults in Iran

open access: yes, 2015
Resistance to oxyimino cephalosporins antibiotics in Enterobacteriaceae is primarily done by the extended spectrum beta-lactamases (ESBLs). Clear identification of risk factors for ESBLs-producing infections is necessary.
Mohammad Kargar   +4 more
core  

Extended-Spectrum Beta-Lactamases (ESBLs) Gene Mutations in Kuwait: How Much Do We Know? Not Much!

open access: yes
Antibiotic resistance is a major problem worldwide, especially with the overuse and misuse of antibiotics. This makes it more challenging to treat patients infected with antibiotic-resistant bacteria, with more costs on the health system.
Ali A. Dashti, Mehrez M. Jadaon
core   +1 more source

Cefdinir binding to a class A β‐lactamase revealed by serial cryo‐crystallography

open access: yesActa Crystallographica Section D, Volume 82, Issue 6, Page 672-682, June 2026.
Serial cryo‐crystallography reveals the structure of the extended‐spectrum β‐lactamase CTX‐M‐14 in complex with the third‐generation cephalosporin antibiotic cefdinir.One of the most common resistance mechanisms against antibiotics employed by Gram‐negative bacteria involves the production of β‐lactamases, resulting in rapid hydrolysis of the ...
Gargi Gore   +4 more
wiley   +1 more source

Phenotypic and genotypic characterization of multi-drug-resistant Escherichia coli isolates harboring blaCTX-M group extended-spectrum β-lactamases recovered from pediatric patients in Shenzhen, southern China

open access: yesInfection and Drug Resistance, 2019
Sandip Patil,1,2 Xiaowen Chen,1,2 Ma Lian,2 Feiqiu Wen1,21Department of Haematology and Oncology, Shenzhen Children’s Hospital, Shenzhen, Guangdong Province 518038, People’s Republic of China; 2Paediatric Research Institute, Shenzhen Children&
Patil S, Chen X, Lian M, Wen F
doaj  

Management of Gram‐Negative Bloodstream Infections With Oral Antibiotics in Solid Organ Transplant Recipients

open access: yesClinical Transplantation, Volume 40, Issue 6, June 2026.
ABSTRACT Background Transitioning from intravenous (IV) to oral antibiotics upon clinical stability in gram‐negative rod (GNR) bloodstream infections (BSI) in immunocompetent patients is effective, with comparable clinical success rates as IV therapy. Studies have historically excluded solid organ transplant (SOT) recipients.
Olubusola Fowowe   +9 more
wiley   +1 more source

Kaempferol restores the susceptibility of ESBLs Escherichia coli to Ceftiofur

open access: yesFrontiers in Microbiology
IntroductionThe development of extended-spectrum-beta-lactamase (ESBLs) Escherichia coli (E. coli) has become a global threat to public health. An alternative strategy to alleviate this is identifying potential natural compounds to restore antibiotic ...
Peng-Cheng Li   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy